Pharmacoepidemiologic study of drug therapyof diabetes mellitus type 2 in hospitals of Volgograd
- Authors: Rogova NV1, Butranova OI1, Rogova NV1, Butranova OI1
-
Affiliations:
- Issue: Vol 4, No 4 (2007)
- Pages: 25-30
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/139998
- ID: 139998
Cite item
Full Text
Abstract
The article contains the results of regional pharmacoepidemiologic research of diabetes mellitus type 2
drug therapy. Analysis of therapy of complications of diabetes with certain drugs demonstrates irrational administration
schemes of hypoglycemic drugs, narrowness of hypoglycemic drug spectrum. Therapy analysis reveals insufficient en
docrinologists' knowledge of clinical pharmacology and rational pharmacotherapy. The results of research are of interest
for further investigation of drug therapy with the aim to optimize drug therapy and to retain costs in diabetes mellitus type 2.
drug therapy. Analysis of therapy of complications of diabetes with certain drugs demonstrates irrational administration
schemes of hypoglycemic drugs, narrowness of hypoglycemic drug spectrum. Therapy analysis reveals insufficient en
docrinologists' knowledge of clinical pharmacology and rational pharmacotherapy. The results of research are of interest
for further investigation of drug therapy with the aim to optimize drug therapy and to retain costs in diabetes mellitus type 2.
References
- Балаболкин М.И. Диабетология. М.: Медицина, 2000.
- Дедов И.И., Сунцов Ю.И., Кудрякова С.В. // Сахарный диабет. 2000. № 3. С. 56-58.
- Дедов И.И., Шестакова М.В., Максимова М.А. Национальные стандарты оказания помощи больным сахарным диабетом. Федеральная целевая программа "Сахарный диабет": метод. рекомендации. М.: Медиа-Сфера, 2002.
- Перечень жизненно необходимых и важнейших лекарственных средств (утвержден распоряжением Правительства Российской Федерации от 21 октября 2004 г. № 1344-р).
- Регистр лекарственных средств в России. Энциклопедия лекарств. 10-й вып. М.: "РЛС-2003".
- International Diabetes federation // Diabetes and Cardiovascular Disease. Time to act. 2001. P. 2-7.
- Liebl A., Neiss A., Spannheimer A., еt al. // Exp. Clin. Endocrinol. Diabet. 2002. Vol. 110. P. 10-16.
Supplementary files
